-
Iran, US race to find crew member of crashed American fighter jet
-
Brown, Tatum fuel Celtics over Bucks, Mavs teen Flagg scores 51
-
Sri Lanka struggles to avert economic collapse over Mideast war
-
Coughlin builds five-shot lead at LPGA Aramco Championship
-
58 tortillas, five hot sauces and one toilet: life aboard spacecraft Orion
-
Artemis mission shares office space -- and physics -- with Apollo
-
Rice will not face NFL action after probe into abuse claims
-
Injured Lakers star Doncic out for rest of NBA regular season
-
Injured Lakers star Doncic out for rest of NBA regular season: team
-
Tirante topples top seed Shelton to reach Houston ATP semi-finals
-
'Extraordinary' views of home as astronauts head towards Moon
-
Pope leads torch-lit Colosseum procession before Easter
-
Vanessa Trump posts supportive message after boyfriend Woods's arrest
-
Northampton edge Castres in 13-try Champions Cup battle
-
Iran hunts crew of crashed US jet, one reported rescued
-
Dembele leads PSG to victory ahead of Liverpool tie
-
MacIntyre seizes Texas Open lead as Masters looms
-
14 dead as Russia launches new daytime attacks on Ukraine
-
French, Japanese ships cross Strait of Hormuz in first since war
-
Pegula reaches WTA Charleston semis with latest three-setter
-
Iran hunts crashed US jet crew, as reports say one rescued
-
Iyer guides Punjab past Chennai to go top of IPL
-
'Sport of the future'? Padel's Miami boom augurs US expansion
-
Wary of news media, Silicon Valley builds its own
-
Iran searches for downed US jet crew, as US media says one member rescued
-
French court rules to extradite Russian who owned Portsmouth football club
-
Senegal-Morocco friendship put to test by Africa Cup of Nations title turmoil
-
For some around Trump, war on Iran is a Christian calling
-
Cuba begins prisoner release after mass pardon
-
US registers strong job growth in boost to Trump
-
10 dead as Russia launches new daytime attacks on Ukraine
-
Arteta hopes League Cup loss will 'fuel' Arsenal season run-in
-
Pogacar welcomes Evenepoel challenge in Flanders
-
US registers strong job growth in March in boost to Trump
-
Judge dismisses Lively sex harassment claim against Baldoni
-
'Line crossed': Chelsea's Fernandez dropped for two matches
-
Liverpool's Alisson to miss Man City, PSG matches, says Slot
-
New Paris mayor vows end to sexual violence in schools
-
Gattuso resigns as Italy coach after World Cup flop
-
Toyota bZ7: Luxury EVs in China
-
EU under pressure as fertiliser costs soar on Middle East war
-
Israel using AI to fine-tune air raid alert system
-
Hegseth fires top US army general in new shake-up
-
Myanmar junta chief elected president by pro-military MPs
-
Greece names new ministers after EU farm scandal resignations
-
Ukraine says six killed in 'massive' Russian daytime attacks
-
Kane ruled out of Bayern match with injury, says Kompany
-
Container ship declaring French ownership passes through Hormuz strait
-
Human remains found on Thai ship attacked in Hormuz strait: firm
-
Cambodian lawmakers approve anti-cybercrime law
Todd H. Lanman to Present First Full U.S. IDE Trial Results for FDA-Approved Synergy Disc(R) at ISASS 2026
Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA approval of motion-preserving cervical disc technology
BEVERLY HILLS, CA / ACCESS Newswire / April 2, 2026 / Following the recent FDA Premarket Approval (PMA) of the Synergy Disc®, Todd H. Lanman, MD, a pioneer in motion-preserving spine surgery, will present the first full results from the U.S. Investigational Device Exemption (IDE) clinical trial at the International Society for the Advancement of Spine Surgery (ISASS) 2026 Annual Conference in Miami Beach, April 9-11. Dr. Lanman served as a principal investigator in the multicenter U.S. IDE study evaluating the motion-preserving cervical artificial disc, developed by Synergy Spine Solutions, for the treatment of single-level degenerative disc disease from C3-C7.

The Synergy Disc received FDA approval after demonstrating superiority to anterior cervical discectomy and fusion (ACDF) on the study's primary endpoint of composite clinical success at 24 months. In the IDE trial, the device achieved an 87.1% composite clinical success rate, significantly higher than the fusion control group.
Additional key findings included:
91.7% of patients achieved clinically meaningful improvement on the Neck Disability Index at two years compared with 75.2% in the fusion group
Lower mean neck pain scores in the Synergy Disc group (15.6 vs. 30.2 in the fusion cohort)
Lower worst arm pain scores (15.0 vs. 32.2)
Improved segmental alignment, with disc angle increasing from 2.6 degrees pre-operatively to 6.5 degrees at 24 months
Higher patient satisfaction, reported by 84.5% of Synergy Disc patients versus 61.6% of fusion patients
"Artificial disc replacement continues to evolve rapidly, and these IDE results tell a clear story - meaningful reductions in neck and arm pain, better function, and higher patient satisfaction over fusion," said Dr. Lanman. "For patients, that is just not a statistic. That is the ability to return to an active, unrestricted life. That is what motion preservation is ultimately about."
The Synergy device incorporates a lordotic polyethylene core engineered to preserve motion while improving spinal alignment, a design intended to reduce the risk of postoperative kyphosis and maintain physiologic cervical curvature.
Dr. Lanman's presentation at ISASS will provide spine surgeons with a detailed review of the IDE trial methodology, clinical outcomes, and implications for the future of cervical motion-preserving surgery.
The International Society for the Advancement of Spine Surgery (ISASS) Annual Conference is one of the premier scientific meetings dedicated to spine innovation and motion-preservation technologies. The 2026 meeting will bring together leading spine surgeons, researchers, and industry innovators to discuss emerging technologies and advances in spinal care.
About Dr. Todd H. Lanman
Todd Lanman, MD has over three decades of experience as a spinal neurosurgeon and has spent the last 25 years practicing spine surgery in Beverly Hills. In addition to being a world-renowned spinal surgeon, Dr. Lanman has also had 11 spinal surgeries including spinal fusions and artificial disc replacements. Because of these experiences as surgeon and as patient, Dr. Lanman brings a unique perspective to his surgical practice.
About Lanman Spinal Neurosurgery
Lanman Spinal Neurosurgery is committed to improving patients' quality of life by relieving pain and restoring spinal motion. The Beverly Hills practice has been at the leading edge of spine health for the past quarter of a century. Lanman Spinal Neurosurgery has and continues to pioneer artificial disc replacement and fusion revision surgeries to help neck and back pain sufferers live their best lives.
About Synergy Spine Solutions
Synergy Spine Solutions is a medical device company focused on improving the quality of life for patients undergoing spine surgery. The company develops motion-preserving technologies designed to treat degenerative disc disease while supporting the spine's natural curvature. Its flagship product, the FDA-approved Synergy Disc®, features a built-in 6-degree lordotic core designed to not only preserve motion but also improve sagittal alignment.
Media Contact:
Brandi Kamenar
Brandi Kamenar Brand Management
BrandiKamenar.com
Email: [email protected]
Phone: (310) 734-6180
SOURCE: Lanman Spinal Neurosurgery
View the original press release on ACCESS Newswire
D.Johnson--AT